SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.80
Ask:
77.20
Spread: 1.40 (1.847%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Total Voting Rights

30 Jun 2020 09:16

RNS Number : 5083R
Accsys Technologies PLC
30 June 2020
 
 

AIM: AXS

Euronext Amsterdam: AXS

 

30 June 2020

 

Accsys Technologies PLC

("Accsys", the "Group" or the "Company")

 

Total Voting Rights

 

Further to the recent announcement of the issue of 727,250 new ordinary shares of €0.05 each in the capital of the Company to the Accsys Employee Benefit Trust and pursuant to 5.6.1 of the Disclosure and Transparency Rules, the Company notifies the market of the following:

The issued share capital of the Company now consists of 164,274,854 ordinary shares of €0.05 each with voting rights. No ordinary shares are held in treasury.

The above figure of 164,274,854 ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules. This figure replaces and supersedes any figure previously announced.

Ends

For further information, please contact:

Accsys Technologies PLC

Robert Harris, CEO

William Rudge, FD

 

via FTI Consulting

Numis Securities Limited -Nominated Adviser and

Joint Broker

Oliver Hardy (NOMAD)

Ben Stoop

 

 

+44 (0) 20 7260 1000

 

 

Investec Bank plc - Joint Broker

 

Carlton Nelson

James Rudd

Alex Wright

 

 

+44 (0) 20 7597 5970

FTI Consulting

Matthew O'Keeffe

Alex Le May

 

+44 (0) 20 3727 1340

 

Off the Grid (The Netherlands)

Frank Neervoort

Yvonne Derkse

 

+31 681 734 236

+31 622 37 96 66

 

Notes to editors:

 

Accsys (Accsys Technologies PLC) is a fast-growing business with a purpose: changing wood to change the world. The company combines chemistry, technology and ingenuity to make high performance wood products that are extremely durable and stable, opening new opportunities for the built environment and giving the world a choice to build sustainably.

Accsys transforms fast-growing, certified sustainable wood into building materials with characteristics that match or better those of man-made, intensely resource-depleting and heavily carbon-polluting alternatives.

The company's primary focus is on the production of Accoya® wood and Tricoya® wood elements, as well as technology licensing via its subsidiaries Titan Wood Limited and Tricoya Technologies Limited. Accsys has its head office in London, UK, production operations in Arnhem, the Netherlands, an American office in Dallas, Texas, and is constructing the world's first Tricoya® plant in Hull, UK.

Accsys is committed to a more sustainable world, and uses abundantly available wood sources that are certified as sustainable. With our business model already aligned with several UN Sustainable Development Goals, Accsys is currently working on identifying further strategic ESG priorities to have an even greater positive impact on the world.

Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'.

More information about Accsys can be found at www.accsysplc.com

 

Accoya® wood is a sustainable, durable and stable solid wood product with exceptional performance, finish and sustainability. Accsys' proprietary acetylation process makes the wood more dimensionally stable and, because it is no longer easily digestible, extremely durable. Produced from certified (e.g. FSC®) sustainable sources, Accoya® wood has many environmental credentials and ecolabels, and is one of very few building materials to be Cradle to Cradle Certified™ at the Gold level, with a Platinum rating for Material Health, confirming that no harmful or toxic additives or chemicals are present to leach out into the environment.

With an up to 50 year warranty and 70+ year service life, the combination of sustainability, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers, specifiers, manufacturers and homeowners. These benefits result in lower maintenance and total cost of ownership while also offering significant sustainability benefits. For more information about Accoya® wood, visit www.accoya.com.

 

Tricoya® wood elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard (MDF) and particle-board.

Panel products made with Tricoya® wood elements are truly durable and stable enough for use outdoors and in wet environments. Combining the sustainability, durability and stability from our acetylation process with the ease of use and quality finish of wood panel products, the enhanced durability and dimensional stability opens new opportunities for the use of these products, making them suitable in applications and environments that previously required solid wood, synthetic or unsustainable materials.

Tricoya® wood elements have been lauded as the first major innovation in the wood composites industry in more than 30 years. For more information about Tricoya® wood elements, visit www.tricoya.com.

In March 2017, Accsys announced the formation of the Tricoya® Consortium to fund, build, own and operate the Tricoya® plant in Hull, UK, through its subsidiary Tricoya Ventures UK Limited. Members of the consortium include BP and the leading manufacturer of sustainable wood-based panels, MEDITE Europe DAC. More information is available at: https://www.accsysplc.com/about-us/accsys-corporate-structure/

 

Wood acetylation is a process which increases the naturally occurring acetyl content of wood, thereby changing its physical properties. When carried out to a sufficient degree throughout the wood, as with Accsys' proprietary process, it significantly reduces the ability of the wood to absorb water without adding any toxic or harmful compounds, elements or substances that were not already present in the wood. This makes it much more dimensionally stable and, because it is no longer easily digestible to most organisms, extremely durable.

 

'Accsys' and 'Accsys Technologies' are trading names of Titan Wood Limited ("TWL"), a wholly-owned subsidiary of Accsys Technologies PLC. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by TWL, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRWPUWGQUPUURU
Date   Source Headline
21st Sep 20164:55 pmRNSAGM Proxy Results
7th Sep 20164:57 pmRNSTotal Voting Rights
30th Aug 20164:35 pmRNSPrice Monitoring Extension
9th Aug 201612:07 pmRNSNotice of AGM
8th Aug 20163:38 pmRNSAccsys Employee Share Participation Plan
20th Jul 20164:37 pmRNSEmployee Benefit Trust and Directors' Interests
28th Jun 20168:42 amRNSDirectors' Interests, Shares to Employees & TVR
15th Jun 20167:00 amRNSPreliminary Results for year ended 31 March 2016
3rd Feb 20167:00 amRNSBP Ventures participates in Tricoya Consortium
1st Feb 201610:17 amRNSTotal Voting Rights
22nd Jan 201612:16 pmRNSEmployee Share Plan
24th Dec 20159:51 amRNSIssue of Equity
4th Dec 20153:59 pmRNSEmployee Benefit Trust
30th Nov 20154:58 pmRNSNotifiable Interest - Henderson Group
30th Nov 20157:00 amRNSInterim results
26th Nov 20157:00 amRNSEnhanced collaboration with Solvay
27th Oct 20154:57 pmRNSNotifiable Interest
17th Sep 20153:17 pmRNSResult of AGM
28th Aug 20152:35 pmRNSTotal Voting Rights
21st Aug 20157:00 amRNSNotice of AGM
15th Jul 20154:27 pmRNSDirector's Interests
2nd Jul 20154:06 pmRNSNotifiable Interest
1st Jul 20154:53 pmRNSEmployee Benefit Trust and Directors' Interests
30th Jun 20154:47 pmRNSDirectors' Interests, Issue of Shares to Employees
16th Jun 20157:00 amRNSPreliminary Results for year ended 31 March 2015
1st Apr 20157:00 amRNSTricoya Technologies Limited Changes
12th Feb 20157:00 amRNSThird Quarter Trading Update
4th Feb 20154:57 pmRNSNotifiable Interest - Majedie UK Equity Fund
2nd Feb 20151:57 pmRNSTotal Voting Rights
22nd Jan 20154:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20154:35 pmRNSPrice Monitoring Extension
13th Jan 20154:23 pmRNSEmployee Share Participation Plan
28th Nov 20147:00 amRNSBoard Appointments
24th Nov 20147:00 amRNSInterim Results
20th Nov 20143:54 pmRNSInterim results release date and webcast
27th Oct 20144:53 pmRNSEmployee Benefit Trust and Directors' Interests
1st Oct 20145:23 pmRNSTotal Voting Rights
30th Sep 20144:56 pmRNSPre Close Trading Update and EBT sale of shares
24th Sep 20142:33 pmRNSDirector Shareholding
19th Sep 201412:00 pmRNSDiamond Wood Licence agreement
11th Sep 20144:08 pmRNSResult of Annual General Meeting
11th Sep 20147:00 amRNSAGM Statement
29th Aug 201410:13 amRNSTotal Voting Rights
19th Aug 20143:52 pmRNSNotice of AGM
13th Aug 20147:00 amRNSInterim Management Statement
12th Aug 20144:00 pmRNSDirectors' Interests and Employee Share Plan
6th Aug 20147:00 amRNSSolvay global co-operation agreement
25th Jul 20147:00 amRNSDiamond Wood Licence Agreement
3rd Jul 20147:00 amRNSPreliminary results for the year ended March 2014
2nd Jul 20144:49 pmRNSNotifiable Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.